Dr. Joseph G. Pressey
Claim this profileCincinnati Children's Hospital Medical Center
Studies Tumors
Studies Recurrence
21 reported clinical trials
69 drugs studied
Area of expertise
1Tumors
Stage IV
NTRK1 positive
NTRK positive
2Recurrence
Stage IV
APC negative
FBXW7 negative
Affiliated Hospitals
Clinical Trials Joseph G. Pressey is currently running
CBL0137
for Cancer
This trial tests CBL0137, a drug that blocks signals inside cancer cells, in patients whose solid tumors, including CNS tumors or lymphoma, have returned or not responded to treatment. By interfering with the cells' internal communication, the drug aims to stop their growth and cause them to die. CBL0137, also known as Curaxin, has shown antitumor activity in multiple cancers, including glioblastoma, renal cell carcinoma, melanoma, neuroblastoma, and small cell lung cancer.
Recruiting1 award Phase 1 & 213 criteria
Tiragolumab + Atezolizumab
for Solid Tumors
This trial studies how well tiragolumab and atezolizumab work in children and adults with difficult-to-treat tumors missing specific genes. These treatments help the immune system attack cancer and stop it from growing. Atezolizumab is an antibody that has been used with other treatments for various cancers.
Recruiting1 award Phase 1 & 214 criteria
More about Joseph G. Pressey
Clinical Trial Related8 years of experience running clinical trials · Led 21 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Joseph G. Pressey has experience with
- Cyclophosphamide
- Dactinomycin
- Larotrectinib
- Ipatasertib
- Binimetinib
- Vincristine
Breakdown of trials Joseph G. Pressey has run
Tumors
Recurrence
Solid Tumors
Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Joseph G. Pressey specialize in?
Joseph G. Pressey focuses on Tumors and Recurrence. In particular, much of their work with Tumors has involved Stage IV patients, or patients who are NTRK1 positive.
Is Joseph G. Pressey currently recruiting for clinical trials?
Yes, Joseph G. Pressey is currently recruiting for 8 clinical trials in Cincinnati Ohio. If you're interested in participating, you should apply.
Are there any treatments that Joseph G. Pressey has studied deeply?
Yes, Joseph G. Pressey has studied treatments such as Cyclophosphamide, Dactinomycin, Larotrectinib.
What is the best way to schedule an appointment with Joseph G. Pressey?
Apply for one of the trials that Joseph G. Pressey is conducting.
What is the office address of Joseph G. Pressey?
The office of Joseph G. Pressey is located at: Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229 United States. This is the address for their practice at the Cincinnati Children's Hospital Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.